These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates. Lemma GL, Wang Z, Hamman MA, Zaheer NA, Gorski JC, Hall SD. Clin Pharmacol Ther; 2006 Mar; 79(3):218-30. PubMed ID: 16513446 [Abstract] [Full Text] [Related]
30. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis. Kharasch ED, Walker A, Hoffer C, Sheffels P. Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460 [Abstract] [Full Text] [Related]
37. Effects of cysteine on the pharmacokinetics of paclitaxel in rats. Lee YK, Han SY, Chin YW, Choi YH. Arch Pharm Res; 2012 Mar; 35(3):509-16. PubMed ID: 22477198 [Abstract] [Full Text] [Related]
38. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats. Choi BC, Choi JS, Han HK. Int J Pharm; 2006 Oct 12; 323(1-2):81-5. PubMed ID: 16806758 [Abstract] [Full Text] [Related]
40. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life. Saari TI, Laine K, Leino K, Valtonen M, Neuvonen PJ, Olkkola KT. Clin Pharmacol Ther; 2006 Nov 12; 80(5):502-8. PubMed ID: 17112806 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]